Back
Amgen, Inc. 10K Form
Buy
54
AMGN
Amgen, Inc.
Last Price:
$369.07
Seasonality Move:
2.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2025-07-15 | 10K | AMGN/Amgen, Inc. Annual |
| 2025-06-15 | 10K | AMGN/Amgen, Inc. Annual |
| 2025-05-15 | 10K | AMGN/Amgen, Inc. Annual |
| 2025-04-15 | 10K | AMGN/Amgen, Inc. Annual |
| 2025-03-15 | 10K | AMGN/Amgen, Inc. Annual |
| 2025-02-15 | 10K | AMGN/Amgen, Inc. Annual |
Receive AMGN News And Ratings
See the #1 stock for the next 7 days that we like better than AMGN
AMGN Financial Statistics
Sales & Book Value
| Annual Sales: | $36.8B |
|---|---|
| Cash Flow: | $1.6B |
| Price / Cash Flow: | 20.09 |
| Annual Sales: | $16.06 |
| Price / Book: | 22.98 |
Profitability
| EPS (TTM): | 14.22840 |
|---|---|
| Net Income (TTM): | $7.7B |
| Gross Margin: | $30.3B |
| Return on Equity: | 102.03% |
| Return on Assets: | 8.57% |
Amgen, Inc. Earnings Forecast
Key Amgen, Inc. Financial Ratios
-
The Gross Profit Margin over the past 42 years for AMGN is 82.52%.
-
The Selling, General & Administrative Expenses for AMGN have been equal to 19.18% of Gross Profit Margin.
-
The Research & Development expenses have been 19.55% of Revenue.
-
The Interest Expense is 35.73% of Operating Income.
-
The Net Earning history of AMGN is 20.98% of Total Revenues.
-
Per Share Earnings over the last 42 years have been positive in 28 years.
Amgen, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AMGN |
| CUSIP: | 031162 |
| Website: | amgen.com |
Debt
| Debt-to-Equity Ratio: | 6.31 |
|---|---|
| Current Ratio: | 1.14 |
| Quick Ratio: | 0.73 |
Price-to-Earnings
| Trailing P/E Ratio: | 25.94 |
|---|---|
| Forward P/E Ratio: | 15.96 |
AMGN Technical Analysis vs Fundamental Analysis
Buy
54
Amgen, Inc. (AMGN)
is a Buy
Is Amgen, Inc. a Buy or a Sell?
-
Amgen, Inc. stock is rated a BuyThe current Amgen, Inc. [AMGN] share price is $369.19. The Score for AMGN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.